Cargando…
Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens
The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692332/ https://www.ncbi.nlm.nih.gov/pubmed/36365112 http://dx.doi.org/10.3390/pharmaceutics14112293 |
_version_ | 1784837238444523520 |
---|---|
author | Alavi, Seyed Ebrahim Raza, Aun Gholami, Max Giles, Michael Al-Sammak, Rayan Ibrahim, Ali Ebrahimi Shahmabadi, Hasan Sharma, Lavanya A. |
author_facet | Alavi, Seyed Ebrahim Raza, Aun Gholami, Max Giles, Michael Al-Sammak, Rayan Ibrahim, Ali Ebrahimi Shahmabadi, Hasan Sharma, Lavanya A. |
author_sort | Alavi, Seyed Ebrahim |
collection | PubMed |
description | The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic microorganisms, and consequently, oral infectious diseases. Systemic administration is frequently used for drug delivery in the treatment of diseases and is associated with the problems, such as drug resistance and dysbiosis. To overcome these challenges, oral drug delivery systems (DDS) have received considerable attention. In this literature review, the related articles are identified, and their findings, in terms of current therapeutic challenges and the applications of DDSs, especially nanoscopic DDSs, for the treatment of oral infectious diseases are highlighted. DDSs are also discussed in terms of structures and therapeutic agents (e.g., antibiotics, antifungals, antiviral, and ions) that they deliver. In addition, strategies (e.g., theranostics, hydrogel, microparticle, strips/fibers, and pH-sensitive nanoparticles), which can improve the treatment outcome of these diseases, are highlighted. |
format | Online Article Text |
id | pubmed-9692332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96923322022-11-26 Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens Alavi, Seyed Ebrahim Raza, Aun Gholami, Max Giles, Michael Al-Sammak, Rayan Ibrahim, Ali Ebrahimi Shahmabadi, Hasan Sharma, Lavanya A. Pharmaceutics Review The oral cavity is a complex ecosystem accommodating various microorganisms (e.g., bacteria and fungi). Various factors, such as diet change and poor oral hygiene, can change the composition of oral microbiota, resulting in the dysbiosis of the oral micro-environment and the emergence of pathogenic microorganisms, and consequently, oral infectious diseases. Systemic administration is frequently used for drug delivery in the treatment of diseases and is associated with the problems, such as drug resistance and dysbiosis. To overcome these challenges, oral drug delivery systems (DDS) have received considerable attention. In this literature review, the related articles are identified, and their findings, in terms of current therapeutic challenges and the applications of DDSs, especially nanoscopic DDSs, for the treatment of oral infectious diseases are highlighted. DDSs are also discussed in terms of structures and therapeutic agents (e.g., antibiotics, antifungals, antiviral, and ions) that they deliver. In addition, strategies (e.g., theranostics, hydrogel, microparticle, strips/fibers, and pH-sensitive nanoparticles), which can improve the treatment outcome of these diseases, are highlighted. MDPI 2022-10-26 /pmc/articles/PMC9692332/ /pubmed/36365112 http://dx.doi.org/10.3390/pharmaceutics14112293 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Alavi, Seyed Ebrahim Raza, Aun Gholami, Max Giles, Michael Al-Sammak, Rayan Ibrahim, Ali Ebrahimi Shahmabadi, Hasan Sharma, Lavanya A. Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens |
title | Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens |
title_full | Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens |
title_fullStr | Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens |
title_full_unstemmed | Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens |
title_short | Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens |
title_sort | advanced drug delivery platforms for the treatment of oral pathogens |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692332/ https://www.ncbi.nlm.nih.gov/pubmed/36365112 http://dx.doi.org/10.3390/pharmaceutics14112293 |
work_keys_str_mv | AT alaviseyedebrahim advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT razaaun advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT gholamimax advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT gilesmichael advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT alsammakrayan advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT ibrahimali advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT ebrahimishahmabadihasan advanceddrugdeliveryplatformsforthetreatmentoforalpathogens AT sharmalavanyaa advanceddrugdeliveryplatformsforthetreatmentoforalpathogens |